Speakers

Dustin Sulak, DO

Dr. Dustin Sulak is an integrative medicine physician with an emphasis in
Osteopathy, energy medicine, mind-body medicine and medical cannabis.
His clinical practice focuses on treating refractory conditions in adults and children with an individualized, health centered approach.

Dr. Sulak is the founder of Integr8 Health, a medical practice with 3 locations in New England that treat over 18,000 patients with medical cannabis, Tested
Labs, a cannabis analytic laboratory and Healer.com, a medical cannabis education resource.

Danielle Saad, DO

Dr. Danielle Saad is a practicing physician board certified in family medicine and Osteopathic manipulative medicine. She is the co-owner of Integr8 Health and the medical director of its Manchester Maine location. Her clinical work focuses on using medical cannabis to treat serious medical conditions like refractory childhood epilepsy, neurological disorders, PTSD, and other chronic complex illnesses. She frequently precepts residents and fellows in cannabinoid, integrative, family, and osteopathic medicine. She also has training in energy medicine, hypnotherapy, homeopathy, herbal medicine, nutrition, and various other alternative and integrative approaches to healing.

Kevin Spelman, PhD

Dr. Kevin Spelman is an internationally recognized expert on the molecular biology and clinical therapeutics of botanical medicines and new product development. A past National Institutes of Health postdoctoral fellow and Marie Curie research fellow in the European Union, Dr. Spelman has published 27 scientific papers and 6 chapters. Dr. Spelman has also practiced clinical phytotherapy for 20 years in various medical centers as well as advised the White House Commission on Complementary and Alternative Medicine and most recently was invited to the White House Office of Science and Technology Policy conference on the microbiome.
Dr. Spelman has also consulted for the Department of Defense on specific therapeutic outcomes using natural products. Past research projects have included the molecular biology of cannabinoid receptors, where he was the first researcher to demonstrate cannabinoid ligands in Zanthoxylum spp. as well as brain and ovarian cancer, clinical investigations, immunological studies and chemical analysis on multiple medicinal plants. Dr. Spelman is an adjunct assistant professor at Massachusetts College of Pharmacy and Health Sciences, an adjunct professor of botanical medicine at National College of Natural Medicine and a distinguished lecturer at Maryland University of Integrative Health. Dr. Spelman is also a member of the prestigious College of Practitioners of Phytotherapy in the UK.

Ethan Russo, MD

Ethan Russo, MD, is a board-certified neurologist, a psychopharmacology researcher, and a Medical Director of PHYTECS. PHYTECS is a biotechnology company researching and developing innovative approaches targeting the human endocannabinoid system (“ECS”). The PHYTECS team pioneered scientific understanding of how the ECS regulates physiological functions including immunity, pain, inflammation, mood, emotion, learning, memory, metabolism, appetite, weight, sleep, embryo development, neuroprotection and stress responses.

From 2003-2014, he served as the Senior Medical Advisor and study physician to GW Pharmaceuticals for numerous Phase I-III clinical trials of Sativex® for alleviation of cancer pain unresponsive to optimized opioid treatment as well as the initial studies of Epidiolex® for intractable epilepsy.

Dr. Russo has served on numerous boards, councils and societies with the role of furthering the scientific, practical understanding, and uses of medical cannabis.
He has also written and published numerous book chapters, and over forty articles in neurology, pain management, cannabis, and ethnobotany.

Greg Gerdeman, PhD

Dr. Greg Gerdeman is a neuroscientist and educator with expertise in the physiological actions of cannabis and the endocannabinoid system (ECS). His Ph.D. dissertation in Pharmacology from Vanderbilt University was one of the first studies to discover endocannabinoids acting as “retrograde messengers” that regulate synaptic plasticity in the brain, findings that have become a foundation to modern understanding of the ECS and the neuroprotective actions of cannabis. He is a member of the International Cannabinoid Research Society (since 1999), the International Association of Cannabinoid Medicine, and the Society of Cannabis Clinicians. It is from a biomedical scientific career spanning over 20 years that Greg became an advocate to reclaim cannabis as a remarkably safe whole-plant medicine.

Dr. Gerdeman’s research has been widely cited in the scientific literature, and highlighted in such diverse publications as Science, National Geographic, Men’s Health and The New York Times. He has co-authored 5 invited book chapters on the ECS and its roles in health and disease. He is a contributor and scientific advisor to Project CBD, an organization dedicated to publicizing research into the medical uses of cannabidiol (CBD) and other components of the cannabis plant. He frequently lectures to physicians and other diverse audiences, and has recently been featured as a cannabinoid expert in Time Magazine, Tampa Bay Times, USA Today and Runner’s World.

Dr. Gerdeman is Assistant Professor of Biology at Eckerd College in St. Petersburg, Florida, where he teaches courses in cell biology, molecular physiology and neuroscience; and continues to conduct experiments investigating the function and genetics of cannabinoid receptors. He is also Chief Scientific Officer for 3 Boys Farm, a rainwater harvesting, solar powered, low carbon footprint, USDA certified organic farm that intends to cultivate medicinal cannabis in the state of Florida.

Michael Eng, MD

Michael has been interested in Integrative Medicine since he saw Traditional Chinese medicine while visiting Beijing, China in 1986. After returning to the United States, he took classes in medicinal and poisonous plants, and ultimately chose to pursue a conventional training in medicine at Duke University School of Medicine. His experiences in patient care were initially disappointing, and he left medicine to work in Environmental Sciences and to study Toxicology. When he completed his MD, he moved to New York City for residency at Beth Israel Medical Center and Mount Sinai Hospital. He was board certified in Anatomic and Clinical Pathology in 2000. He has lived in Maine since then.
While working as a Pathologist at Central Maine Medical Center, Rumford and Bridgton Hospitals, Michael further pursued his interests in spiritual health. He began attending courses at the Kripalu Center for Yoga and Health in Lenox, MA and is now a certified YogaDance instructor leading classes in at CMMC and Bridgton Hospitals. Michael became a Hospice volunteer with Androscoggin Home Care and Hospice (AHCH), where he learned a great deal about healing through love, forgiveness and acceptance. At AHCH he was first exposed to Reiki, and he was trained as a Level 1 practitioner. He has just completed a year-long course in Positive Psychology through Kripalu, and he has been using the teachings as part of his practice at Integr8 Health.
He still practices Pathology at CMHC, but he expanded his practice into patient care in 2013. He has begun training in Osteopathic Manual Manipulation, and he has been astounded to see first-hand the profound healing powers of cannabis. He is delighted to find that patient care outside the traditional practice of medicine is more intimate, individualized and collaborative than what he experienced decades before. He hopes that the additional lessons he has learned from marriage, parenting, hiking, kayaking, dance and yoga infuse his practice with wisdom, respect and intuition.

Zach Walsh, PhD

Zach Walsh, PhD, is a clinical psychologist and an Associate Professor of Psychology at the University of British Columbia, where he directs the Therapeutic Recreational and Problematic Substance Use lab. He has published more than 50 research articles and chapters, and has presented and consulted to diverse governmental, professional, and public audiences on topics related to cannabis, mental health, and public health. His research has been widely cited by international media, and he is the lead investigator for several ongoing studies of the therapeutic use of cannabis including a clinical trial of cannabis for Post-traumatic Stress Disorder. His work has been supported by the Canadian Institutes of Health Research, Social Sciences and Humanities Research Council of Canada, the American Psychological Association, and others.